FSTEX | VENAX | FSTEX / VENAX | |
Total Expense Ratio | 1.27 | 0.09 | 1,411% |
Annual Report Gross Expense Ratio | 1.27 | 0.09 | 1,411% |
Fund Existence | 41 years | 21 years | - |
Gain YTD | 7.987 | 2.198 | 363% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 438M | 8.11B | 5% |
Annual Yield % from dividends | 4.06 | 3.43 | 118% |
Returns for 1 year | 8.62 | 0.24 | 3,625% |
Returns for 3 years | 19.68 | 6.83 | 288% |
Returns for 5 years | 174.59 | 134.79 | 130% |
Returns for 10 years | 9.58 | 14.14 | 68% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRLAX | 20.20 | -0.09 | -0.44% |
T. Rowe Price Latin America | |||
EMGAX | 28.47 | -0.33 | -1.15% |
Allspring Emerging Markets Equity A | |||
GMPPX | 36.33 | -0.49 | -1.33% |
Goldman Sachs Mid Cap Value P | |||
RLLGX | 72.49 | -1.13 | -1.53% |
American Funds SMALLCAP World R6 | |||
HLIDX | 14.70 | -0.23 | -1.54% |
Harding Loevner Intl Dev Mkts Eq Inst |